We evaluate, validate, and guide new reproductive health technologies from concept to real-world clinical implementation — using decentralized research networks and rigorous operational frameworks.
Can results be reproduced across operators, labs, and geographies — both intra- and inter-operator?
Can the product function effectively at clinic level and across workforce skill distributions? Does scale improve consistency?
Does performance and unit economics hold or improve as volume increases? Can clinics implement it without long-term strain?
Reduced cost, improved outcomes, shorter time-to-baby, higher accessibility — the ultimate measure of any innovation.
From basic biology to AI-driven embryo assessment, from microfluidics to genomics — research across multiple frontiers is producing transformative knowledge. Basic markers once used only for reproduction are now recognized as general markers of health.
Yet the current dynamic is broken: start-ups with limited capital pay clinics significant sums to trial their products, only to see them arrive dead on launch or take years to reach clinical practice. The field needs infrastructure to separate signal from noise and move proven innovation into practice.
Innovators expect adoption while clinics expect finished, validated products — creating friction and costly delays at every stage.
No standard framework exists to validate innovation before market entry. Products reach clinics without operational validation or measurable impact proof.
Valuable innovations die from adoption barriers while mediocre ones persist on marketing alone. Clinics bear all adoption risk.
Early-stage or growth-stage technologies that need validation, pilots, or pathways to market. We provide rigorous, real-world validation that clinics trust — reducing costs and accelerating adoption across multiple markets.
Sites for research, trials, and operational validation. First access to rigorously validated innovations, with protocols, SOPs, and implementation strategies that reduce risk and improve outcomes.
The ultimate beneficiaries. Their outcomes and cost structure guide all decisions. When you see RHRI validation, you know it works in the real world — proven to improve outcomes, reduce costs, and shorten time-to-baby.
The infrastructure that ensures innovation investments deliver real-world value — expanding the market, accelerating translation, and maximizing every dollar invested in reproductive health.
Collaboration with clinics in multiple jurisdictions. Flexible incorporation to leverage regulatory and operational advantages internationally.
Scientific rigor meets real-world practicality. We maintain the highest standards while staying grounded in clinical reality.
We're enablers, not gatekeepers. We connect innovators, clinics, academia, and patients around shared goals and standards.
AI-driven improvements in reproductive health workflows — from embryo assessment algorithms to clinical decision tools.
Tools and devices that improve precision, automation, or consistency in lab and clinical environments.
Re-engineering workflows to improve efficiency, reduce cost, or shorten time-to-treatment.
Products requiring clinical research to validate outcomes, biomarkers, or biological mechanisms.
Establish organizational structure and governance. Recruit founding team. Develop validation protocols. Complete first validation studies. Publish methodology and initial results through peer review.
Expand partner clinic network across regions. Launch formal membership programs. Build the validation registry. Achieve financial sustainability and brand recognition.
Establish international presence. "RHRI Validated" becomes a recognized mark of quality. Influence clinical guidelines. Launch educational programs and certifications.
Join us in transforming how innovation reaches reproductive health practice.
Get InvolvedA global institute built to bridge the gap between innovation and clinical implementation in reproductive health and assisted reproductive technology.
To drive high-impact innovation in reproductive health. We exist to ensure that the explosion of scientific knowledge and technological capability translates into meaningful improvements in patient care, clinical efficiency, and equitable access.
To evaluate, validate, and guide new technologies from concept to real-world clinical implementation — using decentralized research networks and rigorous operational frameworks. We connect innovators, clinics, academia, and patients around shared standards, accelerate high-value technologies from prototype to practice, and ensure every new technology delivers measurable patient value.
A global system that accelerates safe, scalable, and impactful innovation in reproductive health. By 2036, RHRI is recognized globally as the gold standard for reproductive health innovation validation — the first call innovators make, the trusted source clinics consult, and the essential infrastructure that grew the entire market.
We occupy the intersection of rigorous science and practical clinical application that no other entity currently fills. We are not a regulatory body, a research lab, or a consulting firm. We validate, enable, connect, standardize, and accelerate — complementing the existing ecosystem, not competing with it.
No single headquarters — talent and partners distributed globally. We collaborate with clinics in multiple jurisdictions, leveraging regulatory and operational advantages internationally. Our flexible incorporation strategy allows us to run pilots and research where conditions are optimal, connecting innovators, clinics, and patients through a decentralized network.
Transparent funding, diverse governance, published methodology. Without independence, our validation is worthless.
Data over opinions. Real-world results over marketing claims. Our credibility depends on honesty about what works.
We partner to enable success, connect stakeholders, and create win-win outcomes.
Protocols, results, methodology, and governance — all public by default.
Does it help patients? Improve outcomes? Reduce costs? We exist for patients.
Sustainable impact over quick wins. Building for decades, not months.
The field evolves rapidly. We evolve with it — learning, adapting, sharing.
Fertility and reproductive-health executive focused on scaling clinics and building high-performance operating models across the Americas and Europe. Previously CEO of Fertilidad Integral; currently Senior Advisor to RHEA and GenPrime.
SVP of Clinics at TMRW Life Sciences. Embryologist and medical technologist with 20+ years in reproductive medicine. Founder of NOVA Genomics and owner of Perch Fertility in New Jersey.
Reproductive scientist and researcher at Universitat Autònoma de Barcelona (UAB). Her work in the Eugin Group research ecosystem bridges rigorous lab science with clinically relevant questions shaping modern IVF practice.
Whether you're an innovator, a clinic, a researcher, or a funder — we'd love to connect.
Contact UsEvery innovation is evaluated through four foundational pillars that together form RHRI's universal decision-making rubric — ensuring only technologies with real-world merit reach clinical practice.
Can results be reproduced across operators, labs, and geographies — both intra- and inter-operator? We test for scientific consistency, protocol clarity, and quality control.
Can the product function effectively at clinic level and across workforce skill distributions? We evaluate workflow integration, resource requirements, and training burden. Does scale improve consistency?
Does performance and unit economics hold or improve as case volume increases? Can clinics implement it without long-term operational or financial strain?
Reduced cost. Improved outcomes. Shorter time-to-baby. Higher accessibility or quality of experience. Technology for technology's sake helps no one.
Our framework goes beyond academic evaluation. We test technologies in real-world clinical environments through our decentralized network, ensuring that validation reflects actual operating conditions — not just controlled lab settings.
Each pillar generates specific, measurable criteria that innovators must meet. This transparency helps both innovators understand what's required and clinics trust what's been validated.
Talent and partners distributed globally. Research conducted where regulatory and operational conditions are most favorable.
Partnerships with clinics across regions enable diverse patient populations and regulatory environments in every study.
Strategic legal structures that leverage international advantages for research, funding, and operations.
Every pilot and research project is placed where conditions maximize learning, efficiency, and real-world relevance.
Our framework is designed to give innovators a clear path from prototype to clinical implementation.
Submit for EvaluationOrganized into four distinct categories, our research and validation efforts cover the full spectrum of reproductive health innovation — from digital tools to biological breakthroughs.
Technologies focused on digital or AI-driven improvements in reproductive health workflows. These tools enhance clinical decision-making, automate assessment processes, and bring data-driven precision to every stage of treatment.
Tools and devices that improve precision, automation, or consistency in lab and clinical environments. From robotics to microfluidics, these innovations address the physical infrastructure of reproductive medicine.
Re-engineering workflows to improve efficiency, reduce cost, or shorten time-to-treatment. These innovations focus on how care is delivered, not just what tools are used — optimizing the full patient journey.
Products requiring clinical research to validate outcomes, biomarkers, or biological mechanisms. These innovations push the boundaries of what's scientifically possible in reproductive health.
Each vertical presents unique validation challenges. Software may require large datasets and diverse clinical environments to test AI reliability. Hardware demands hands-on testing across different operator skill levels. Process innovations need before-and-after metrics across multiple sites. Biotech requires rigorous clinical trial design.
Our decentralized network of partner clinics ensures that every innovation category can be tested in the conditions that matter most — real-world clinical practice with real patients and real operators.
Consistent results across settings and operators.
Works at the scale clinics actually need.
Economically and operationally viable long-term.
Measurably improves outcomes or access.
Whether it's software, hardware, a new process, or a biotech breakthrough — we want to hear from you.
Get in Touch